Nektar Therapeutics
NKTR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $41 | $43 | $39 | $44 |
| Short-Term Investments | $229 | $133 | $180 | $211 |
| Receivables | $1 | $1 | $2 | $2 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $281 | $187 | $230 | $261 |
| Property Plant & Equip (Net) | $10 | $11 | $11 | $12 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $5 | $5 | $10 | $26 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $5 | $5 | $5 | $5 |
| Total NC Assets | $20 | $21 | $26 | $43 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $301 | $208 | $256 | $304 |
| Liabilities | – | – | – | – |
| Payables | $16 | $14 | $18 | $12 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $9 | $7 | $5 | $6 |
| Total Curr. Liab. | $66 | $71 | $71 | $61 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $80 | $86 | $93 | $99 |
| Total NC Liab. | $150 | $160 | $172 | $182 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $92 | $96 | $100 | $103 |
| Total Liabilities | $216 | $232 | $243 | $243 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$3,724 | -$3,689 | -$3,647 | -$3,596 |
| AOCI | $0 | -$0 | $0 | $0 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $85 | -$24 | $14 | $61 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $301 | $208 | $256 | $304 |
| Net Debt | -$41 | -$43 | -$39 | -$44 |